147 related articles for article (PubMed ID: 35951148)
1. Ocular surface squamous neoplasia with 360° limbal involvement: a study of 130 patients.
Vempuluru VS; Ghose N; Pattnaik M; Mohamed A; Kaliki S
Int Ophthalmol; 2023 Feb; 43(2):609-618. PubMed ID: 35951148
[TBL] [Abstract][Full Text] [Related]
2. Ocular Surface Squamous Neoplasia in 200 Patients: A Case-Control Study of Immunosuppression Resulting from Human Immunodeficiency Virus versus Immunocompetency.
Kamal S; Kaliki S; Mishra DK; Batra J; Naik MN
Ophthalmology; 2015 Aug; 122(8):1688-94. PubMed ID: 26050538
[TBL] [Abstract][Full Text] [Related]
3. American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.
Chauhan S; Sen S; Sharma A; Tandon R; Kashyap S; Pushker N; Vanathi M; Sharma N
Arch Pathol Lab Med; 2014 Nov; 138(11):1488-94. PubMed ID: 25357110
[TBL] [Abstract][Full Text] [Related]
4. Primary limbal stem cell transplantation in the surgical management of extensive ocular surface squamous neoplasia involving the limbus.
Narang P; Mittal V; Menon V; Bhaduri A; Chaudhuri BR; Honavar SG
Indian J Ophthalmol; 2018 Nov; 66(11):1569-1573. PubMed ID: 30355863
[TBL] [Abstract][Full Text] [Related]
5. Nodulo-Ulcerative Ocular Surface Squamous Neoplasia in 6 Patients: A Rare Presentation.
Kaliki S; Freitag SK; Chodosh J
Cornea; 2017 Mar; 36(3):322-326. PubMed ID: 27749454
[TBL] [Abstract][Full Text] [Related]
6. Ocular surface squamous neoplasia: analysis based on the 8th American Joint Committee on Cancer classification.
Singh S; Mohamed A; Kaliki S
Int Ophthalmol; 2019 Jun; 39(6):1283-1291. PubMed ID: 29749567
[TBL] [Abstract][Full Text] [Related]
7. Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.
Kapoor AG; Vempuluru VS; Laghimshetty S; Roy A; Sharma S; Mishra DK; Mohamed A; Kaliki S
Cornea; 2022 Mar; 41(3):294-303. PubMed ID: 34294636
[TBL] [Abstract][Full Text] [Related]
8. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
9. Histopathological spectrum of ocular surface squamous neoplasia: A retrospective study of 776 lesions.
Mishra DK; Taneja S; Singh V; Veena U; Kaliki S
Indian J Pathol Microbiol; 2022; 65(1):3-7. PubMed ID: 35074957
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Simple Limbal Epithelial Transplantation After Surgical Excision of Ocular Surface Squamous Neoplasia.
Kaliki S; Mohammad FA; Tahiliani P; Sangwan VS
Am J Ophthalmol; 2017 Feb; 174():68-75. PubMed ID: 27832940
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
12. Ocular surface squamous neoplasia in India: a study of 438 patients.
Kaliki S; Vempuluru VS; Ghose N; Gunda S; Vithalani NM; Sultana S; Ganguly A; Bejjanki KM; Jakati S; Mishra DK
Int Ophthalmol; 2022 Jun; 42(6):1915-1926. PubMed ID: 35094225
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Optical Coherence Tomography Comparison Between Ocular Surface Squamous Neoplasia and Squamous Metaplasia.
Stevens SM; Reyes-Capo DP; Patel U; Choudhary A; Khzam RA; Tang V; Galor A; Karp CL; Dubovy S
Cornea; 2023 Apr; 42(4):429-434. PubMed ID: 35439777
[TBL] [Abstract][Full Text] [Related]
14. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Galor A; Karp CL; Oellers P; Kao AA; Abdelaziz A; Feuer W; Dubovy SR
Ophthalmology; 2012 Oct; 119(10):1974-81. PubMed ID: 22704832
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface squamous neoplasia with orbital tumour extension: risk factors and outcomes.
Kaliki S; Wagh RD; Vempuluru VS; Kapoor AG; Jakati S; Mishra DK; Mohamed A
Eye (Lond); 2023 Feb; 37(3):446-452. PubMed ID: 35115716
[TBL] [Abstract][Full Text] [Related]
16. Histopathology-guided management of ocular surface squamous neoplasia with corneal stromal or scleral invasion using ruthenium-106 plaque brachytherapy.
Rao R; Honavar SG; Lahane S; Mulay K; Reddy VP
Br J Ophthalmol; 2023 May; 107(5):621-626. PubMed ID: 34844918
[TBL] [Abstract][Full Text] [Related]
17. Assessing Profile and Treatment Outcome in Patients of Ocular Surface Squamous Neoplasia (OSSN).
Shrestha E; Banstola L; Man I; Gurung B; Gurung H; Adhikari HB
Nepal J Ophthalmol; 2019 Jul; 11(22):181-188. PubMed ID: 32792695
[TBL] [Abstract][Full Text] [Related]
18. Clinical Presentation of Ocular Surface Squamous Neoplasia in Kenya.
Gichuhi S; Macharia E; Kabiru J; Zindamoyen AM; Rono H; Ollando E; Wanyonyi L; Wachira J; Munene R; Onyuma T; Sagoo MS; Weiss HA; Burton MJ
JAMA Ophthalmol; 2015 Nov; 133(11):1305-13. PubMed ID: 26378395
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
Ma IH; Hu FR; Wang IJ; Chen WL; Hsu YJ; Chu HS; Yuan CT; Hou YC
J Formos Med Assoc; 2019 Apr; 118(4):776-782. PubMed ID: 30266199
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of presumed ocular surface squamous neoplasia: A report of 8 cases.
Vempuluru VS; Ghose N; Vithalani NM; Sultana S; Kaliki S
Eur J Ophthalmol; 2022 Sep; 32(5):3029-3034. PubMed ID: 34747253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
